ArticleMedical molecular morphology2026
Relationship between nutritional indicators and clinicopathological factors, including immune cell densities in the tumor microenvironment, in patients with colorectal cancer.
Article in Medical molecular morphology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
We retrospectively analyzed 116 cases of colorectal cancer (CRC) to evaluate the relationship between nutritional indicators (NIs) and clinicopathological features, including immune cell infiltration in the tumor microenvironment. The geriatric nutritional risk index (GNRI), prognostic nutritional index (PNI), modified Glasgow prognostic score (mGPS), Controlling Nutritional Status (CONUT) score, and neutrophil-to-lymphocyte ratio (NLR) were assessed. Immune cell densities (CD3, CD8, Foxp3, Iba1, CD163) were quantified by immunohistochemistry. Poor NIs were associated with older age, lower body mass index, advanced tumor stage, elevated tumor markers, and reduced immune cell infiltration. Specifically, low GNRI and high mGPS correlated with reduced Foxp3-positive cells; low PNI with reduced Foxp3- and CD20-positive cells; and high NLR with reduced CD3-, CD8-, CD20-, and Iba1-positive cells. The GNRI- and mGPS-abnormal groups showed significantly reduced Foxp3-positive cells, and the CONUT-abnormal group exhibited decreased CD3- and CD20-positive cells. Patients with abnormal NLR had significantly worse cancer-specific survival. However, it was not identified as an independent prognostic factor in the multivariate analysis. Nutritional impairment in CRC patients is linked not only to poor clinical outcomes, but also to a tumor-promoting microenvironment characterized by diminished immune cell infiltration. Assessing NIs may help guide nutritional and therapeutic strategies to improve prognosis.
Indexed as
Identifiers
41504903What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.